Rules Suggestions
The Advisory Committees evaluate in the first instance suggestions to amend the Federal Rules.
Name of Individual and/or Organization | Date Received | Committee | Rule or Form | Status |
---|---|---|---|---|
Altec, Inc. (20-EV-A) | 01/31/2020 | Evidence | Rule 702 | Considered |
50 Companies (20-EV-B) | 03/02/2020 | Evidence | Rule 702 | Considered |
Washington Legal Foundation (20-EV-C) | 03/12/2020 | Evidence | Rule 702 | Considered |
Washington Legal Foundation (20-EV-D) | 05/06/2020 | Evidence | Rule 702 | Considered |
Thomas Sheehan (20-EV-E) | 06/09/2020 | Evidence | Rule 702 | Considered |
Federation of Defense & Corporate Counsel (20-EV-F) | 06/30/2020 | Evidence | Rule 702 | Considered |
International Association of Defense Counsel (20-EV-H) | 07/31/2020 | Evidence | Rule 702 | Considered |
National Association of Mutual Insurance Companies (20-EV-I) | 03/02/2020 | Evidence | Rule 702 | Pending consideration |
David Bernstein and Eric Lasker (20-EV-J) | 08/31/2020 | Evidence | Rule 702 | Pending consideration |
Debra Baker (20-EV-K) | 09/03/2020 | Evidence | Rule 702 | Pending consideration |
Coalition for Litigation Justice, Inc (20-EV-G) | 07/29/2020 | Evidence | Rule 702 | Considered |
Ford Motor Company (20-EV-L) | 09/26/2020 | Evidence | Rule 702 | Considered |
Ballard Spahr (20-EV-M) | 09/30/2020 | Evidence | Rule 702 | Considered |
Kuchler Polk Weiner LLC (20-EV-N) | 09/30/2020 | Evidence | Rule 702 | Considered |
Bayer Corporation (20-EV-O) | 10/02/2020 | Evidence | Rule 702 | Considered |
American Association for Justice (20-EV-P) | 10/02/2020 | Evidence | Rule 702 | Considered |
Sheila Birnbaum and Mark Cheffo (20-EV-Q) | 10/02/2020 | Evidence | Rule 702 | Considered |
Robert Scott and Marquel Jordan (20-EV-R) | 10/05/2020 | Evidence | Rule 702 | Considered |
J. Gordon Cooney Jr. and William Peterson (20-EV-S) | 09/30/2020 | Evidence | Rule 702 | Considered |
State Farm (20-EV-T) | 10/09/2020 | Evidence | Rule 702 | Considered |
Peter Choate (20-EV-U) | 10/10/2020 | Evidence | Rule 702 | Considered |
Glaxo Smith Kline (20-EV-V) | 10/12/2020 | Evidence | Rule 702 | Considered |
Georgia Ainsworth (20-EV-W) | 10/15/2020 | Evidence | Rule 702 | Considered |
Chris Fabricant/Innocence Project et al. (20-EV-X) | 10/16/2020 | Evidence | Rule 702 | Considered |
Lawyers for Civil Justice (20-EV-Y) | 10/20/2020 | Evidence | Rule 702 | Considered |
Covington & Burling LLP (20-EV-Z) | 10/23/2020 | Evidence | Rule 702 | Considered |
Department of Justice (20-EV-AA) | 11/06/2020 | Evidence | Rule 702 | Considered |
Shook Hardy & Bacon (20-EV-BB) | 11/09/2020 | Evidence | Rule 702 | Considered |
U.S. Chamber Institute for Legal Reform (20-EV-CC) | 11/09/2020 | Evidence | Rule 702 | Considered |
Beveridge & Diamond (20-EV-DD) | 11/10/2020 | Evidence | Rule 702 | Considered |